innoviva glp-1 receptor agonist weight management diabetes treatments cardinal health GLP-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon Efficacy and Safety of Glucagon-Like
Description
Your gut produces this hormone after eating
Although these findings offer reassurance regarding the safety of these drugs, further validation is essential
It also promotes hepatic fat oxidation, which is a fancy way of saying it tells your liver to burn stored fat for fuel
Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation
